Acomplia Launch Could Come This Year, Sanofi-Aventis Says
Sanofi-Aventis' weight loss/smoking cessation agent Acomplia (rimonabant) could be launched as early as the end of the year, Exec VP-Pharmaceutical Operations Hanspeter Spek said
Sanofi-Aventis' weight loss/smoking cessation agent Acomplia (rimonabant) could be launched as early as the end of the year, Exec VP-Pharmaceutical Operations Hanspeter Spek said